Say what you will about Scott Gottlieb, but the Food and Drug Administration commissioner is nothing if not loquacious. Since assuming the job last year, he has become notable not only for his plain-spoken remarks and helping the Trump administration focus on drug costs, but also for issuing a steady stream of communiques.
How many?
In the first half of 2018, he released 53 so-called commissioner statements, versus just four during the comparable period a year earlier. These were among 72 general announcements, up from only seven that were released during the same time frame in 2017, according to a tally by Mark Senak, a senior vice president and partner at the FleishmanHillard public relations firm who writes the Eye on FDA blog.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
